Your session is about to expire
← Back to Search
Bevacizumab for Cervical Cancer
Study Summary
This trial will test whether combining two chemotherapy drugs with bevacizumab and pembrolizumab is more effective in treating cervical cancer than the standard chemotherapy regimen.
- Cervical Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What health conditions are most often addressed with Pembrolizumab?
"Pembrolizumab is indicated to treat various maladies and can be used in cases of Hodgkin Disease, Squamous cell carcinoma, and Melanoma."
How much risk do patients face when using Pembrolizumab?
"The safety of Pembrolizumab is estimated to be a 2 on our scale, as this Phase 2 trial has data indicating it is safe but not yet proven effective."
Are there any open slots for participants in this trial?
"According to the information on clinicaltrials.gov, this trial is presently looking for volunteers and has been since its first posting on September 6th 2018. The details were most recently updated October 1st 2022."
How many individuals have taken part in this clinical research?
"Correct, according to clinicaltrials.gov this medical trial is currently recruiting patients. It was initially announced on September 6th 2018 and was last updated October 1st 2022. 40 participants must be sourced from a single location in order for the study to continue."
Share this study with friends
Copy Link
Messenger